SEC Form 4 · accession 0001209191-16-107657
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas M Van Oort
Officer — Chairman and CEO
Period of report
Mar 8, 2016
Accepted (ET)
Mar 10, 2016 · 5:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 8, 2016 | M | 1,000,000 | $0.80 | A | 2,125,000 | D | |
| Common StockF2 | Mar 8, 2016 | S | 290,000 | $7.19 | D | 1,835,000 | D | |
| Common StockF2 | Mar 9, 2016 | S | 160,000 | $6.93 | D | 1,675,000 | D | |
| Common StockF3 | holding | — | — | — | 187,500 | I | Conundrum Capital Partners |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| StockOption (Right to Buy)F4 | $0.80 | Mar 8, 2016 | X | 1,000,000 | D | Dec 31, 2009 | Mar 15, 2016 | Common Stock | 1,000,000 | 0 | D |
| Stock Option (Right to Buy)F5 | $1.71 | holding | — | — | — | Feb 14, 2013 | Feb 14, 2017 | Common Stock | 800,000 | 800,000 | D |
Explanation of responses
- F1Includes 125,000 shares of restricted stock that the Board of Directors approved and granted on April 15, 2014. The terms of the award call for the stock to vest on the third anniversary of the grant date as long as Mr. Van Oort is still an employee of the Company. This was disclosed in our Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on July 29, 2014.
- F2Common stock was sold on March 8, 2016 and March 9, 2016 and proceeds from the sale were used as payment of the exercise price and tax liability associated with the exercise of the 1,000,000 stock options expiring on March 15, 2016. The total shares disposed of were 450,000 shares and 550,000 were retained.
- F3Conundrum Capital Partners, LLC is a limited liability partnership 50% owned by Mr. VanOort. Mr.VanOort is a managing partner of Conundrum Capital Partners, LLC.
- F4On March 19, 2009, Mr. Van Oort was granted options to purchase 1,000,000 shares. These options are being exercised as they expire on March 15, 2016.
- F5On February 14, 2012, Mr. VanOort was granted options to purchase 800,000 shares. These shares vest equally over each of the first four anniversaries of the grant date.